Blue Horseshoe Stocks

Blue Horseshoe Stocks: OMER Review & More

Omeros Corp. OMER

We had a nice intraday mover in OMER yesterday after we caught the stock gapping up in early trading. Tagging it for observation in our premarket report was definitely a good move as the stock ran straight out of the gate from a low 22.51, and reached as high as 30.21 shortly after 11AM.

That’s an intraday increase of 34% which, for a stock in this price range, is quite impressive. If any of our readers were able to take advantage of the stock’s exceptional daily performance following our alert, we salute you!

Tesla Motors, Inc. TSLA – Options Update

We reminded our subscribers yesterday of the options idea we formulated on Monday for TSLA Weekly $250-265 Calls, highlighting some of the early gains we saw out of contracts in the low end of the range. We also reiterated our interest in tracking the action in that range consistently over the course of the week.

It was a good thing that we did, because TSLA responded in kind, surging past the $260-mark toward the end of the session. As expected, that move was accompanied by some heavy activity within our specified range. Here’s a breakdown of some of the top profit possibilities:

$260 Calls – Range: 1.60-4.20 – Max Gain: 163%
$262.50 Calls – Range: 1.09-2.94 – Max Gain: 170%
$265 Calls – Range: .69-1.97 – Max Gain: 186%

Ascent Solar Technologies, Inc. ASTI – Bottom Watch

We’ve taken notice of ASTI this midweek as the stock has been on an absolute backslide for an extended period. One peek at the following snapshot reveals a heavily oversold chart. We’re going to put ASTI on bottom-watch, because when a rebound does occur, it could be very significant.

Cannabis Science, Inc CBIS

It’s been quite a long time since we checked in with CBIS. We’re making note of the stock this morning on the heels of a big PR yesterday with sent it into overdrive. We’ll be on the lookout for a possible continuation of momentum into today’s session.

Blue Horseshoe Stocks: NUGN Recap & More

NuGene International, Inc. NUGN

We came back to NUGN just in the nick of time yesterday, to start the week off on a high note. We identified the stock’s finding of support on Friday after a recent backslide, and pointed out the significance of yesterday’s PR. We postulated that the concurrence of those events could lead to a rebound on the chart, and the stock followed our expectations to the letter.

From a low of 1.66, the it traded up to a high-of-day at 2.30; that’s an intraday pop of 39% We’ll be in the lookout for a protracted rebound out of NUGN as it attempts to regain the considerable amount of ground that it’s lost over the past month. We’ll want to see the stock maintain support at or above last Wednesday’s swing-low of 1.92 on any pullbacks in order for us to remain interested.

Pazoo, Inc. PZOO

Speaking of coming back to familiar stocks at an opportune time; we want to turn our attention back to PZOO this morning. In addition to releasing a PR containing information about the early success of wholly-owned subsidiary CannabisKing’s ‘Accuvape’ line (PR Below), the chart has reached a point where a rebound appears imminent.

As we’ve pointed out below, the stock has maintained what we’ve come to recognize as a base-level of support at .0045, and is beginning to show signs that yet another recovery is in the cards. Recent activity qualifies PZOO as a ‘Double Bottom’ (>>Investopedia Definition) which lends support to that conclusion. We’ll be watching the trading action in PZOO heavily this week as a result.

WHIPPANY, N.J., Aug. 18, 2015 /PRNewswire/ — Pazoo, Inc. (OTC Pinks: PZOO), is pleased to report that 100% wholly owned subsidiary CannabisKing Distribution, LLC, in just one week after training, completes multiple sales for the AccuVape product line in Nevada, Colorado, New Jersey and New York. After such an initial sales success, CannabisKing has lined up dozens of sales calls over the next few weeks, most from new client referrals. CannabisKing is confident they will be able to introduce the AccuVape line to a larger market share, nationally. >>VIEW FULL PR

Tesla Motors, Inc. TSLA – Options Update

Yesterday we identified potential intraday and/or intraweek trading opportunities in TSLA Weekly $250-265 Calls. We’ll be monitoring that range consistently over the course of the week, and saw the first significant action yesterday in the $250 and $252.50’s:

$250 Calls – Range: 5.09-7.70 – Max Gain: 51%
$252.50 Calls – Range: 3.89-5.92 – Max Gain: 52%

Extended Watchlist:
OMER(Big-Gapper)

Blue Horseshoe Stocks: Fresh News Plays & More

Fresh News Plays

We’ve got a couple of stocks that we’ve been tracking this summer coming out with noteworthy press in the early hours this morning, we’re going to want to increase our alertness level for each of them as we kick off a new trading week.

NuGene International, Inc. NUGN – NUGN is appearing in the news feed with a substantial revelation at an opportune time this morning. The stock took an absolute beating last week, and just began to find its footing off of a previous support level on Friday. At the moment the stock is extremely oversold. Coupling that with the addition of this morning’s PR announcing the company’s Q2 revenue growth of more than 150% over the prior year, conditions could be just right for a rebound. We’ll be on a sharp lookout for that possibility.

___

AVEO Pharmaceuticals, Inc. AVEO

AVEO stock is gapping up immensely in premarket trading on the strength of a deal the company just announced with Novartis. The potential for both a momentum play and/or a bounce play is elevated. We’ll need to see it maintain support at or above 2.20 (a previous resistance point) on any pullbacks to remain interested. With high profile news like this, it’s quite possible that it will do so.

AVEO Oncology (AVEO) today announced an exclusive, worldwide license agreement with Novartis for the development and commercialization of AVEO’s first-in-class, potent, humanized inhibitory antibody targeting growth differentiation factor 15 (GDF15), AV-380, and related antibodies>>>Full PR

Tesla Motors, Inc. TSLA – Options Idea

We’d like to submit a potential options trading idea to start the week. Morgan Stanley has raised their price target on the stock (Currently valued in the mid-$250’s) from $280 to $465, and TSLA is gapping up on the heels of that announcement. As a result, we see the potential for some intraday and/or intraweek trading opportunities in the range of TSLA Weekly $250-265 Calls.

Extended Watchlist:
ZU(Gapping Up), SFXE & XGTI(Both Oversold, on Bottom Watch)

Blue Horseshoe Stocks: Options, Bottom-Plays & More

OncoNova Therapeutics, Inc. ONTX

ONTX is hitting the scanner as a premarket gapper this morning, on the heels of a PR announcing a “pivotal” Phase III drug trial. (>>View PR)

The stock’s 1-year analyst price target of $5 doesn’t seem all that far-fetched, especially if ONTX can break past resistance in the channel between 3.00-3.25 as we’ve outlined on the following chart snapshot. Also looking ripe are the RSI which is creeping toward the 50-line, and the MACD in the midst of bullish cross.

We’ll continue to keep an eye on the stock today and into next week.

Tesla Motors, Inc. TSLA – Options Idea

To carry on our recent tradition of presenting weekly options ideas on Friday (which has yielded us some truly epic gains), we have TSLA. Remember, trading weekly contracts so close to expiration carries added risk, so we always need to exercise extra caution when doing so.

The stock is responding well to news that the company’s share offering would be increased to nearly 2.7M shares, or $642.5M. As a result of this increased activity, we’ve identified the range in which the heaviest action is likely to occur in the event of a sustained uptrend.

Our main target area will be TSLA Weekly $242.50-247.50 Calls. We’ll of course begin with the lowest strike price, which is currently in the money, and roll it up from there as needed, depending on how the day’s trading activity unfolds.

Potential Bottom-Play

Pacific Sunwear of California, Inc. PSUN – We also want to quickly make mention of PSUN, which we’ve noticed has come down to new 52-week lows. As our regulars our well aware by now, these sorts of plays have been an area of extreme success lately. Just take a look at the chart to see what we mean. This is a stock that is sorely due for a rebound, and we intend to be watching closely for when that occurs.

Extended Watchlist:
PBMD, AREN, FIT

Blue Horseshoe Stocks: MZEI, SPY Recaps & More

Medizone International, Inc. MZEI

Continuing our recent good fortune with selecting stocks ripe for a rebound off of their 52-week lows, we listed MZEI as a point of interest in yesterday’s premarket report.

We want to quote what we said verbatim, as the stock’s performance so closely coincided with our expectations. We stated: “MZEI fell off a cliff yesterday…We’re going to slate this stock as a potential recovery play- support prior to that epic beating was in the .07-08 range, so we’ll be on the lookout for a rebound back to that region of the chart.”

As the session commenced, MZEI gapped up just past that .07-mark to .07225, and proceeded to run promptly to a daily high of .09, a 25% intraday move, and held a good portion of those gains into an eight-cent close. We’ll keep this one on our radars to watch for the possibility of a sustained rebound.

ETF Options Recap

Both of our options-trading ideas for ETFs worked out nicely yesterday:

Direxion Daily Gold Miners Index Bull 3X Shares (NUGT) – Our idea of tracking the NUGT Sept. 4th $5 Calls yesterday provided a significant chance for traders to make a double-bagger, as they rose from .27 to a high of .55, marking a total possible profit of 104%

*Side Note* We spotted abnormal volume in the NUGT 09/18 $5-7 Calls during yesterday’s session, so we’ll tag those for observation in coming weeks. NUGT is dipping back in the premarket today, which could provide us with a good buying opportunity.

___

SPDR S&P 500 ETF Trust (SPY) – We flagged SPY Weekly $206 Calls in our extended watchlist yesterday, and were instantaneously rewarded. Those contracts ran hard, jumping from a low of 1.08 all the way up to 3.24. That was good for a nice, round, 200% jump on the day, so congrats to any of our readers who took advantage of the heads up!

Eleven Biotherapeutics, Inc. EBIO

We also want to observe activity in EBIO as we head into week’s end. On Wednesday, they provided an update on one of their clinical trials, and this morning they’ve got an earnings drop (Links Below), leading to another premarket gap-up. We’ve pointed out the key aspects on the following chart snapshot, including the fact that an normous gap exists, the fillinf of which could mean significant added gains.

Extended Watchlist:
PLNR, OHGI, IMUC, CGRA(Marijuana News)